Charles Conway, Chief Scientific Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), bought 4,000 shares at $17.00 ($68K) on 2017-05-09, disclosed to the SEC on 2017-05-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.